BPO 0.00% 0.3¢ bioprospect limited

Ann: Rights Issue Announcement amendment , page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,187 Posts.
    lightbulb Created with Sketch. 497
    SLA TO could then allow them to gain the IP on Equine R&D, and AGRIPRO and GI-Guard were not that far off commercialisation using BioA base, thus alt CGNC path & re-trials not necessary. If they hit before SPP then they only need to double their holding on market [& pay for options] hey presto 20% all set for HTO unless Leo does a Lebanese fandango and a back room deal is done that puts all that Opes/Ip court action to bed. Either way minor holders may be just background noise to that dance if any.

    I found it a bit odd that the Oct BioNews added the cosmetic aromatic use of Eremophilone Oil as an option - at $1000/L wholesale that will need to be value added into ReGen range to make a dent in BL. Don't see why a boutique DYI "organic" termite treatment could be marketed at a premium [except Ensystex would do a bit of foot stomping]. Peter Mays old AEPMA mates wouldnt appreciate it if rather than getting a pest control bloke in at $750/$1k p/a a eco friendly 5L DYI spray pack could be sold off the shelf at Bunnings for 1/3 that [which may be commercially viable] Im sure ACA will help out with a bit of Aussie product promotion.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.